These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 71463)

  • 21. Blood groups and HLA antigens in patients with abdominal aortic aneurysms.
    Norrgård O; Cedergren B; Angquist KA; Beckman L
    Hum Hered; 1984; 34(1):9-13. PubMed ID: 6429031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells.
    Zarling JM; Raich PC; McKeough M; Bach FH
    Nature; 1976 Aug; 262(5570):691-3. PubMed ID: 1066526
    [No Abstract]   [Full Text] [Related]  

  • 23. Weakening of antigen D and development of anti-D in a patient with acute myeloid leukaemia.
    Mujeeb SA; Siddiqui S; Khursheed T; Hashmi MR
    J Pak Med Assoc; 1989 Dec; 39(12):324-5. PubMed ID: 2517439
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of relationship of ABO and Rh blood group, and HLA antigens with parasitic diseases.
    Bouree P; Bonnot G
    J Egypt Soc Parasitol; 1989 Jun; 19(1):67-73. PubMed ID: 2496187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].
    Fujita A; Fujisawa S; Hyo R; Kuwabara H; Yamazaki E; Tomita N; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Jan; 49(1):51-4. PubMed ID: 18277597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis the incidence of HL-A-system antigen incidence in children treated for acute lymphoblastic leukemia].
    Vuković I; Susaković N; Dujić A; Gligorović V; Stojimirović E; Marković V
    Bilt Hematol Transfuz; 1977; 5(1):37-42. PubMed ID: 411481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes of the antigenic determinants of the ABO system during a course of acute leukemia].
    Susaković N; Dinić B
    Bilt Hematol Transfuz; 1976; 4(1-2):109-16. PubMed ID: 60100
    [No Abstract]   [Full Text] [Related]  

  • 29. [Integration of the recipient's genome by transplanted cells of the donor bone marrow].
    Zotikov EA; Poreshina LP; Demidova IA; Liubimova LS
    Klin Lab Diagn; 2003 Feb; (2):8-10. PubMed ID: 12688207
    [No Abstract]   [Full Text] [Related]  

  • 30. Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
    Cocks P; Powles RL; Chapuis B; Alexander P
    Br J Cancer; 1977 Mar; 35(3):273-9. PubMed ID: 139910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The HLA system in acute leukaemia and Hodgkin's disease.
    Harris R; Lawler SD; Oliver RT
    Br Med Bull; 1978 Sep; 34(3):301-4. PubMed ID: 363226
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
    Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
    Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia.
    Bird GW; Wingham J; Pippard MJ; Hoult JG; Melikian V
    Br J Haematol; 1976 Jun; 33(2):289-94. PubMed ID: 1063594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute myelogenous leukaemia of adults: diagnosis, prognosis and treatment (author's transl)].
    Abbrederis K; Michlmayr G; Schmalzl F; Huber H; Braunsteiner H
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1743-7. PubMed ID: 4517776
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia.
    Zhang R; Zhao F; Wang J
    Hematology; 2015 Dec; 20(10):555-60. PubMed ID: 26067370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Survival in acute myeloid leukaemia.
    Willoughby ML; Russell SJ; Graham-Pole JR
    Lancet; 1975 Dec; 2(7948):1302. PubMed ID: 54817
    [No Abstract]   [Full Text] [Related]  

  • 38. Leukaemia in Nigerians. I. The acute leukaemias.
    Essien EM
    Afr J Med Sci; 1972 Apr; 3(2):117-30. PubMed ID: 4623911
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy for acute myelogenous leukaemia.
    Powles RL; Crowther D; Bateman CJ; Beard ME; McElwain TJ; Russell J; Lister TA; Whitehouse JM; Wrigley PF; Pike M; Alexander P; Fairley GH
    Br J Cancer; 1973 Nov; 28(5):365-76. PubMed ID: 4271320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twins with two different fathers identified by HLA.
    Terasaki PI; Gjertson D; Bernoco D; Perdue S; Mickey MR; Bond J
    N Engl J Med; 1978 Sep; 299(11):590-2. PubMed ID: 98711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.